Ovarian Cancer
A Phase 2 Study Evaluating The Efficacy And Safety Of TORL-1-23 In Women With Advanced Platinum Resistant Epithelial Ovarian Cancer (Including Primary Peritoneal And Fallopian Tube Cancers) Expressing Claudin 6 (TORL123-002)
- Details
ClinicalTrials.gov ID:
NCT06690775
Diagnosis Type:
NA
USOR Number:
- Address
,
P: